Skip to main content
. 2021 Sep 27;12:737105. doi: 10.3389/fphar.2021.737105

FIGURE 3.

FIGURE 3

Stratification analysis of hazard ratios of cardiovascular disease among systemic lupus erythematosus patients treated with Chinese herbal medicines (in comparison with systemic lupus erythematosus patients treated without Chinese herbal medicine). Adjusted for age, gender, insured amount, urbanization level, comorbidities, and baseline drugs. HR, hazard ratio; CI: confidence interval; ESRD, end-stage renal disease; NSAID, nonsteroidal anti-inflammatory drug; CHM, Chinese herbal medicine. a Azathioprine, methotrexate, leflunomide, mycophenolic acid, cyclosporine, and cyclophosphamide. *p-value < 0.05.